Loading clinical trials...
Loading clinical trials...
Prospective Clinical Trial to Detect Liver Cancer Through Quantification of cfDNA Methylation in Blood Samples: A LAM Insight Trial Study
Conditions
Interventions
Multi-analyte blood Test
Locations
38
United States
AZ Liver Health (Chandler)
Chandler, Arizona, United States
AZ Liver Health (Glendale, Peoria)
Peoria, Arizona, United States
AZ Liver Health (Tucson)
Tucson, Arizona, United States
Banner University Hospital (University of Arizona Tucson)
Tucson, Arizona, United States
Alliance Research Centers
Irvine, California, United States
University of South California
Los Angeles, California, United States
Start Date
February 4, 2019
Primary Completion Date
February 1, 2023
Completion Date
June 30, 2024
Last Updated
May 31, 2024
NCT07439939
NCT06680583
NCT06169592
NCT07275554
NCT06855056
NCT06092385
Lead Sponsor
Helio Genomics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions